BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantMG
Merck Global Health Innovation Fund
Activity from announced rounds
Activity in this selectionOct 19, 2026 · Sep 20, 2026
Merck Global Health Innovation Fund is the US Merck/MSD investment fund identified in N-Power and Merck Digital Sciences Studio material.
Recorded funding activity
N-Power combines oncology care with trial-data services. DropGenie miniaturizes gene-editing workflows, while Infinimmune develops antibody medicines. The fund remains separate from the Merck parent and Germany’s Merck and M Ventures.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $75M 1 disclosed · full round size, not this investor’s share